Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia: A Study in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide

Trial Profile

Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia: A Study in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jan 2017

At a glance

  • Drugs Calfactant (Primary)
  • Indications Bronchopulmonary dysplasia
  • Focus Therapeutic Use
  • Acronyms TOLSURF
  • Most Recent Events

    • 16 Jan 2017 Results assessing effects on respiratory outcomes at 1 year corrected age (n=450) published in the Journal of Pediatrics
    • 20 Oct 2015 Primary endpoint has not been met. (Survival without BPD at 36 weeks post menstrual age.), as per an article published in the Journal of Pediatrics
    • 20 Oct 2015 Status changed from active, no longer recruiting to completed, as per an article published in the Journal of Pediatrics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top